Chengu Niu
Overview
Explore the profile of Chengu Niu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niu C, Zhang J, Okolo 3rd P, Daglilar E
Semin Oncol
. 2025 Mar;
52(2):152333.
PMID: 40073717
Globally, gastric cancer ranks as the fifth most common cancer and is the third most common cause of malignancy-associated mortality. Although surgery is the primary treatment option for gastric cancer,...
2.
Malik S, Naqvi S, Shadali A, Khan H, Christof M, Niu C, et al.
Dig Dis Sci
. 2025 Mar;
PMID: 40038211
Background And Aims: Recent systematic reviews and meta-analyses (SRMAs) have shown inconsistent effectiveness of FMT among patients with IBD. This study aimed to appraise the evidence for clinically relevant outcomes...
3.
Joshi U, Budhathoki P, Gaire S, Yadav S, Niu C, Agrawal V, et al.
Clin Breast Cancer
. 2025 Feb;
PMID: 39934001
Background: Most published data on EMC consists of individual case reports, and survival outcomes are not clearly defined to guide evidence-based management. Methods: All women with a histologic diagnosis of...
4.
Li X, Zhang J, Malik S, Jain A, Wang M, Niu C
Clin Res Hepatol Gastroenterol
. 2025 Feb;
49(3):102544.
PMID: 39894344
Background: Autoimmune hepatitis (AIH) is a chronic inflammatory disease primarily affecting the liver, with a higher prevalence among women of reproductive age. The latest nationwide statistics regarding its impact on...
5.
Mostafa M, Eltaher B, Egiza H, Gouli S, Mahmoud A, Kharel H, et al.
Eur J Cancer Prev
. 2024 Nov;
PMID: 39560460
Colorectal cancer is the third most common malignancy in the USA and accounts for more than 1 million deaths worldwide with screening shown to reduce CRC mortality. This meta-analysis analyzed...
6.
Niu C, Zou Y, Dong M, Niu Y
Nutrition
. 2024 Nov;
130:112610.
PMID: 39546872
Objectives: Current Parkinson's disease (PD) medications treat symptoms; none can slow down or arrest the disease progression. Disease-modifying therapies for PD remain an urgent unmet clinical need. This review was...
7.
Niu C, Zhang J, Okolo 3rd P
Inflammopharmacology
. 2024 Nov;
33(2):785-798.
PMID: 39497005
Acute pancreatitis is a potentially life-threatening inflammatory disorder of the exocrine pancreas characterized by early activation of pancreatic enzymes followed by macrophage-driven inflammation, and pancreatic acinar cell death. The most...
8.
Niu C, Zhang J, Farooq U, Zahid S, Okolo P
Endosc Int Open
. 2024 Oct;
12(10):E1150-E1159.
PMID: 39398447
Endoscopic submucosal dissection (ESD) is a minimally invasive and effective treatment for gastrointestinal lesions. It carries potential risks such as bleeding and perforation. This meta-analysis was conducted to assess the...
9.
Niu C, Dong M, Niu Y
Phytother Res
. 2024 Sep;
38(12):5567-5582.
PMID: 39290049
Oxidative stress is recognized to have a central role in the initiation and progression of Parkinson's disease (PD). Within the brain, neurons are particularly sensitive to oxidation due in part...
10.
Niu C, Zhang J, Orakzai A, Boppana L, Elkhapery A, Verghese B, et al.
Clin Res Hepatol Gastroenterol
. 2024 Sep;
48(9):102463.
PMID: 39276856
Background: Percutaneous endoscopic gastrostomy (PEG) tubes are commonly inserted to provide a route for enteral feeding in patients who are unlikely to have adequate oral intake for prolonged periods of...